SCHEMBL2530767

SCHEMBL2530767

CCCCCCCCCCCCC(c1ccccc1)N(CCCCCCCCCCCC)CCCCCCCCCCCC

nearest known ligand 0.50

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 2/20 0.50
KCNH2 Q12809 7/20 0.47
CSNK1E P49674 1/20 0.43
HTR2A P28223 3/20 0.41
HRH1 P35367 2/20 0.41
ICMT O60725 1/20 0.40
ALB P02768 1/20 0.40
OPRM1 P35372 2/20 0.39
OPRD1 P41143 2/20 0.39
OPRK1 P41145 2/20 0.39
DRD2 P14416 1/20 0.39
DRD3 P35462 1/20 0.39
OPRL1 P41146 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9846066 0.95 SIGMAR1 (0.47) SIGMAR1KCNH2CSNK1EHTR2AHRH1
SCHEMBL27916857 0.89 SIGMAR1 (0.44) SIGMAR1KCNH2HTR2AHRH1
SCHEMBL27309973 0.88 SIGMAR1 (0.47) SIGMAR1KCNH2CSNK1EHTR2AHRH1
SCHEMBL28279553 0.88 KCNH2 (0.51) SIGMAR1KCNH2HTR2AHRH1ICMT
Hydrochloric Acid SCHEMBL3635488 0.86 SIGMAR1 (0.46) SIGMAR1KCNH2CSNK1EHTR2AHRH1
Hydrochloric Acid SCHEMBL28704227 0.86 SIGMAR1 (0.46) SIGMAR1KCNH2CSNK1EHTR2AHRH1
Hydrochloric Acid SCHEMBL28705373 0.86 SIGMAR1 (0.46) SIGMAR1KCNH2CSNK1EHTR2AHRH1
Bromide SCHEMBL28704238 0.86 SIGMAR1 (0.46) SIGMAR1KCNH2CSNK1EHTR2AHRH1
Hydrochloric Acid SCHEMBL28712149 0.86 SIGMAR1 (0.46) SIGMAR1KCNH2CSNK1EHTR2AHRH1
Bromide SCHEMBL28705368 0.86 SIGMAR1 (0.46) SIGMAR1KCNH2CSNK1EHTR2AHRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8039625-B2 Coronene charge-transport materials, methods of fabrication thereof, and methods of use thereof GEORGIA TECH RESEARCH CORPORATION (US) 2011-10-18 US disclosed
US-20090044863-A1 CORONENE CHARGE-TRANSPORT MATERIALS, METHODS OF FABRICATION THEREOF, AND METHODS OF USE THEREOF NATIONAL SCIENCE FOUNDATION 2009-02-19 US disclosed
WO-2006093965-A2 CORONENE CHARGE-TRANSPORT MATERIALS, METHODS OF FABRICATION THEREOF, AND METHODS OF USE THEREOF GEORGIA TECH RESEARCH CORPORATION (US) 2006-09-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090044863-A1 CORONENE CHARGE-TRANSPORT MATERIALS, METHODS OF FABRICATION THEREOF, AND METHODS OF USE THEREOF SLC18A3, CORO1C, SLC18A1 SIGMAR1 2736/4885KCNH2 995/4885CSNK1E 2110/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.